TG103 Injection

· CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TG103 Injection, covering 2021-10-01 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus [Phase 3]